{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:56:33Z","timestamp":1789610193470,"version":"build-2803163510"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,3,10]],"date-time":"2015-03-10T00:00:00Z","timestamp":1425945600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s11940-015-0341-x","type":"journal-article","created":{"date-parts":[[2015,3,9]],"date-time":"2015-03-09T02:46:50Z","timestamp":1425869210000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Treatment of Meni\u00e8re\u2019s Disease"],"prefix":"10.1007","volume":"17","author":[{"given":"Jeffrey D.","family":"Sharon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Trevino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Schubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Carey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,10]]},"reference":[{"issue":"7","key":"341_CR1","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1001\/archneur.58.7.1151","volume":"58","author":"RW Baloh","year":"2001","unstructured":"Baloh RW. Prosper Meniere and his disease. Arch Neurol. 2001;58(7):1151\u20136.","journal-title":"Arch Neurol"},{"issue":"3","key":"341_CR2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0194-5998(95)70100-1","volume":"113","author":"EM Monsell","year":"1995","unstructured":"Monsell EM et al. Committee on hearing and equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere\u2019s disease. Otolaryngol Head Neck Surg. 1995;113(3):181\u20135. This article established commonly used guidelines for diagnosing Meni\u00e8re\u2019s disease and evaluating treatment efficacy.","journal-title":"Otolaryngol. Head Neck Surg"},{"key":"341_CR3","unstructured":"Society B. Diagnostic criteria for Meni\u00e8re\u2019s disease. Available from: http:\/\/www.jvr-web.org\/images\/55807-Lopez-Escamez.pdf"},{"issue":"11","key":"341_CR4","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1177\/000348948909801108","volume":"98","author":"SD Rauch","year":"1989","unstructured":"Rauch SD, Merchant SN, Thedinger BA. Meniere\u2019s syndrome and endolymphatic hydrops. Double-blind temporal bone study. Ann Otol Rhinol Laryngol. 1989;98(11):873\u201383. A temporal bone study that helped clarify the relationship of histological endolymphatic hydrops and clinical Meni\u00e8re\u2019s disease.","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"3","key":"341_CR5","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00129492-200405000-00022","volume":"25","author":"SD Rauch","year":"2004","unstructured":"Rauch SD et al. Vestibular evoked myogenic potentials show altered tuning in patients with Meniere\u2019s disease. Otol Neurotol. 2004;25(3):333\u20138.","journal-title":"Otol Neurotol"},{"issue":"5","key":"341_CR6","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1177\/0194599811434073","volume":"146","author":"MG Zuniga","year":"2012","unstructured":"Zuniga MG et al. Can vestibular-evoked myogenic potentials help differentiate Meniere disease from vestibular migraine? Otolaryngol Head Neck Surg. 2012;146(5):788\u201396.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"341_CR7","first-page":"852714","volume":"2012","author":"J Hornibrook","year":"2012","unstructured":"Hornibrook J et al. Transtympanic electrocochleography for the diagnosis of Meniere\u2019s disease. Int J Otolaryngol. 2012;2012:852714.","journal-title":"Int J Otolaryngol"},{"issue":"5","key":"341_CR8","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/MAO.0b013e318219ff9a","volume":"32","author":"GM Claes","year":"2011","unstructured":"Claes GM et al. The Meniere\u2019s disease index: an objective correlate of Meniere\u2019s disease, based on audiometric and electrocochleographic data. Otol Neurotol. 2011;32(5):887\u201392.","journal-title":"Otol Neurotol"},{"issue":"3","key":"341_CR9","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/MLG.0b013e31802c300c","volume":"117","author":"T Nakashima","year":"2007","unstructured":"Nakashima T et al. Visualization of endolymphatic hydrops in patients with Meniere\u2019s disease. Laryngoscope. 2007;117(3):415\u201320. This important paper showed that it was possible to visualize endolymphatic hydrops in Meni\u00e8re\u2019s disease using high resolution MRI and intratympanic contrast.","journal-title":"Laryngoscope"},{"issue":"5","key":"341_CR10","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.otc.2010.06.001","volume":"43","author":"I Pyykko","year":"2010","unstructured":"Pyykko I et al. Magnetic resonance imaging of the inner ear in Meniere\u2019s disease. Otolaryngol Clin North Am. 2010;43(5):1059\u201380.","journal-title":"Otolaryngol Clin North Am"},{"issue":"8","key":"341_CR11","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1097\/MAO.0b013e318268d087","volume":"33","author":"R Gurkov","year":"2012","unstructured":"Gurkov R et al. Herniation of the membranous labyrinth into the horizontal semicircular canal is correlated with impaired caloric response in Meniere\u2019s disease. Otol Neurotol. 2012;33(8):1375\u20139. This study is important because it showed that novel MRI techniques used to visualize endolymphatic hydrops in vivo do correlate with objective measures like vestibular testing.","journal-title":"Otol Neurotol"},{"issue":"12","key":"341_CR12","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1007\/s00405-011-1573-3","volume":"268","author":"R Gurkov","year":"2011","unstructured":"Gurkov R et al. In vivo visualization of endolymphatic hydrops in patients with Meniere\u2019s disease: correlation with audiovestibular function. Eur Arch Otorhinolaryngol. 2011;268(12):1743\u20138.","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"1","key":"341_CR13","first-page":"67","volume":"18","author":"SE Kinney","year":"1997","unstructured":"Kinney SE, Sandridge SA, Newman CW. Long-term effects of Meniere\u2019s disease on hearing and quality of life. Am J Otol. 1997;18(1):67\u201373.","journal-title":"Am J Otol"},{"issue":"9636","key":"341_CR14","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0140-6736(08)61161-7","volume":"372","author":"H Sajjadi","year":"2008","unstructured":"Sajjadi H, Paparella MM. Meniere\u2019s disease. Lancet. 2008;372(9636):406\u201314.","journal-title":"Lancet"},{"issue":"1","key":"341_CR15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00019052-200402000-00004","volume":"17","author":"LB Minor","year":"2004","unstructured":"Minor LB, Schessel DA, Carey JP. Meniere\u2019s disease. Curr Opin Neurol. 2004;17(1):9\u201316.","journal-title":"Curr Opin Neurol"},{"issue":"2","key":"341_CR16","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1258\/0022215053419871","volume":"119","author":"WK Smith","year":"2005","unstructured":"Smith WK, Sankar V, Pfleiderer AG. A national survey amongst UK otolaryngologists regarding the treatment of Meniere\u2019s disease. J Laryngol Otol. 2005;119(2):102\u20135.","journal-title":"J Laryngol Otol"},{"issue":"5","key":"341_CR17","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.otc.2010.05.005","volume":"43","author":"SL Greenberg","year":"2010","unstructured":"Greenberg SL, Nedzelski JM. Medical and noninvasive therapy for Meniere\u2019s disease. Otolaryngol Clin North Am. 2010;43(5):1081\u201390.","journal-title":"Otolaryngol Clin North Am"},{"key":"341_CR18","first-page":"CD003599","volume":"3","author":"AS Thirlwall","year":"2006","unstructured":"Thirlwall AS, Kundu S. Diuretics for Meniere\u2019s disease or syndrome. Cochrane Database Syst Rev. 2006;3:CD003599.","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"341_CR19","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000275884","volume":"48","author":"GW Deelen van","year":"1986","unstructured":"van Deelen GW, Huizing EH. Use of a diuretic (Dyazide) in the treatment of Meniere\u2019s disease. A double-blind cross-over placebo-controlled study. ORL J Otorhinolaryngol Relat Spec. 1986;48(5):287\u201392.","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"issue":"6","key":"341_CR20","doi-asserted-by":"crossref","first-page":"e39086","DOI":"10.1371\/journal.pone.0039086","volume":"7","author":"F Ihler","year":"2012","unstructured":"Ihler F et al. Betahistine exerts a dose-dependent effect on cochlear stria vascularis blood flow in guinea pigs in vivo. PLoS One. 2012;7(6):e39086.","journal-title":"PLoS One"},{"key":"341_CR21","doi-asserted-by":"crossref","unstructured":"James AL and Burton MJ. Betahistine for Meniere\u2019s disease or syndrome. Cochrane Database Syst Rev. 2001(1):CD001873. This systematic review examined the evidence for betahistine, which is widely used around the world as a treatment for Meni\u00e8re\u2019s disease.","DOI":"10.1002\/14651858.CD001873"},{"issue":"5","key":"341_CR22","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1080\/00016480701724912","volume":"128","author":"M Strupp","year":"2008","unstructured":"Strupp M et al. Long-term prophylactic treatment of attacks of vertigo in Meniere\u2019s disease\u2014comparison of a high with a low dosage of betahistine in an open trial. Acta Otolaryngol. 2008;128(5):520\u20134.","journal-title":"Acta Otolaryngol"},{"issue":"8","key":"341_CR23","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s00405-011-1647-2","volume":"268","author":"F Lezius","year":"2011","unstructured":"Lezius F et al. High-dosage betahistine dihydrochloride between 288 and 480\u00a0mg\/day in patients with severe Meniere\u2019s disease: a case series. Eur Arch Otorhinolaryngol. 2011;268(8):1237\u201340.","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"20","key":"341_CR24","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1001\/jama.2011.679","volume":"305","author":"SD Rauch","year":"2011","unstructured":"Rauch SD et al. Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: a randomized trial. JAMA. 2011;305(20):2071\u20139.","journal-title":"JAMA"},{"issue":"6","key":"341_CR25","doi-asserted-by":"crossref","first-page":"F1127","DOI":"10.1152\/ajprenal.00387.2003","volume":"286","author":"SR Pondugula","year":"2004","unstructured":"Pondugula SR et al. Glucocorticoids stimulate cation absorption by semicircular canal duct epithelium via epithelial sodium channel. Am J Physiol Renal Physiol. 2004;286(6):F1127\u201335.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"2","key":"341_CR26","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.otohns.2005.05.010","volume":"133","author":"MA Garduno-Anaya","year":"2005","unstructured":"Garduno-Anaya MA et al. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Meniere\u2019s disease: a two-year prospective, placebo-controlled, double-blind, randomized trial. Otolaryngol Head Neck Surg. 2005;133(2):285\u201394. A well-conducted trial that helped establish the utility of intratympanic steroids as a treatment for Meni\u00e8re\u2019s disease.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"341_CR27","doi-asserted-by":"crossref","unstructured":"Phillips JS and Westerberg B. Intratympanic steroids for Meniere\u2019s disease or syndrome. Cochrane Database Syst Rev. 2011(7):CD008514. Systematic review that looked at evidence for intratympanic steroids in treating Meni\u00e8re\u2019s disease.","DOI":"10.1002\/14651858.CD008514.pub2"},{"issue":"1","key":"341_CR28","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/mao.0b013e31815dbafc","volume":"29","author":"MS Boleas-Aguirre","year":"2008","unstructured":"Boleas-Aguirre MS et al. Longitudinal results with intratympanic dexamethasone in the treatment of Meniere\u2019s disease. Otol Neurotol. 2008;29(1):33\u20138.","journal-title":"Otol Neurotol"},{"issue":"3","key":"341_CR29","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1177\/0194599811429432","volume":"146","author":"AP Casani","year":"2012","unstructured":"Casani AP et al. Intratympanic treatment of intractable unilateral Meniere disease: gentamicin or dexamethasone? A randomized controlled trial. Otolaryngol Head Neck Surg. 2012;146(3):430\u20137.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"4","key":"341_CR30","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s10162-007-0093-8","volume":"8","author":"S Lyford-Pike","year":"2007","unstructured":"Lyford-Pike S et al. Gentamicin is primarily localized in vestibular type I hair cells after intratympanic administration. J Assoc Res Otolaryngol. 2007;8(4):497\u2013508. This animal study showed the differential uptake of gentamicin by type 1 vestibular hair cells.","journal-title":"J Assoc Res Otolaryngol"},{"issue":"4","key":"341_CR31","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s101620010053","volume":"3","author":"JP Carey","year":"2002","unstructured":"Carey JP et al. Changes in the three-dimensional angular vestibulo-ocular reflex following intratympanic gentamicin for Meniere\u2019s disease. J Assoc Res Otolaryngol. 2002;3(4):430\u201343. This study examined the physiologic changes that occurred to the vestibulo-ocular reflex after gentamicin administration.","journal-title":"J Assoc Res Otolaryngol"},{"issue":"2","key":"341_CR32","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1080\/00016480410016621","volume":"124","author":"R Stokroos","year":"2004","unstructured":"Stokroos R, Kingma H. Selective vestibular ablation by intratympanic gentamicin in patients with unilateral active Meniere\u2019s disease: a prospective, double-blind, placebo-controlled, randomized clinical trial. Acta Otolaryngol. 2004;124(2):172\u20135. A placebo controlled study that added to the body of literature establishing the effectiveness of gentamicin in treating Meni\u00e8re\u2019s disease.","journal-title":"Acta Otolaryngol"},{"issue":"8","key":"341_CR33","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1080\/00016480701762458","volume":"128","author":"RJ Postema","year":"2008","unstructured":"Postema RJ et al. Intratympanic gentamicin therapy for control of vertigo in unilateral Meniere\u2019s disease: a prospective, double-blind, randomized, placebo-controlled trial. Acta Otolaryngol. 2008;128(8):876\u201380. Another well conducted study that showed the effectiveness of gentamicin for treating Meni\u00e8re\u2019s disease.","journal-title":"Acta Otolaryngol"},{"issue":"5","key":"341_CR34","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/00005537-200305000-00009","volume":"113","author":"IC Wu","year":"2003","unstructured":"Wu IC, Minor LB. Long-term hearing outcome in patients receiving intratympanic gentamicin for Meniere\u2019s disease. Laryngoscope. 2003;113(5):815\u201320.","journal-title":"Laryngoscope"},{"issue":"4","key":"341_CR35","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/lary.20055","volume":"119","author":"KD Nguyen","year":"2009","unstructured":"Nguyen KD et al. Time course of repeated intratympanic gentamicin for Meniere\u2019s disease. Laryngoscope. 2009;119(4):792\u20138.","journal-title":"Laryngoscope"},{"issue":"8","key":"341_CR36","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1097\/00005537-200408000-00010","volume":"114","author":"R Perez","year":"2004","unstructured":"Perez R, Chen JM, Nedzelski JM. The status of the contralateral ear in established unilateral Meniere\u2019s disease. Laryngoscope. 2004;114(8):1373\u20136.","journal-title":"Laryngoscope"},{"issue":"5","key":"341_CR37","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/MAO.0b013e3181a66d2b","volume":"30","author":"BT Crane","year":"2009","unstructured":"Crane BT et al. Middle ear exploration in patients with Meniere\u2019s disease who have failed outpatient intratympanic gentamicin therapy. Otol Neurotol. 2009;30(5):619\u201324.","journal-title":"Otol Neurotol"},{"issue":"2","key":"341_CR38","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10162-002-3025-7","volume":"4","author":"H Satoh","year":"2003","unstructured":"Satoh H et al. Proinflammatory cytokine expression in the endolymphatic sac during inner ear inflammation. J Assoc Res Otolaryngol. 2003;4(2):139\u201347.","journal-title":"J Assoc Res Otolaryngol"},{"issue":"12","key":"341_CR39","first-page":"1862","volume":"20","author":"G Portmann","year":"1927","unstructured":"Portmann G. The saccus endolymphaticus and an operation for draining for the relief of vertigo. Proc R Soc Med. 1927;20(12):1862\u20137.","journal-title":"Proc R Soc Med"},{"issue":"6","key":"341_CR40","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1097\/MAO.0000000000000324","volume":"35","author":"AJ Sood","year":"2014","unstructured":"Sood AJ et al. Endolymphatic sac surgery for Meniere\u2019s disease: a systematic review and meta-analysis. Otol Neurotol. 2014;35(6):1033\u201345. A systematic review that examined the evidence for endolymphatic sac surgery in Meni\u00e8re's diease.","journal-title":"Otol Neurotol"},{"key":"341_CR41","first-page":"CD005395","volume":"2","author":"B Pullens","year":"2013","unstructured":"Pullens B, Verschuur HP, van Benthem PP. Surgery for Meniere\u2019s disease. Cochrane Database Syst Rev. 2013;2:CD005395.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"341_CR42","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1067\/mhn.2000.101575","volume":"122","author":"DB Welling","year":"2000","unstructured":"Welling DB, Nagaraja HN. Endolymphatic mastoid shunt: a reevaluation of efficacy. Otolaryngol Head Neck Surg. 2000;122(3):340\u20135.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"4","key":"341_CR43","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/MAO.0b013e31821553ce","volume":"32","author":"JW Chung","year":"2011","unstructured":"Chung JW et al. Histopathology after endolymphatic sac surgery for Meniere\u2019s syndrome. Otol Neurotol. 2011;32(4):660\u20134.","journal-title":"Otol Neurotol"},{"issue":"3","key":"341_CR44","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.otohns.2006.08.031","volume":"136","author":"GM Brinson","year":"2007","unstructured":"Brinson GM, Chen DA, Arriaga MA. Endolymphatic mastoid shunt versus endolymphatic sac decompression for Meniere\u2019s disease. Otolaryngol Head Neck Surg. 2007;136(3):415\u201321.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"2","key":"341_CR45","first-page":"209","volume":"20","author":"LB Minor","year":"1999","unstructured":"Minor LB. Intratympanic gentamicin for control of vertigo in Meniere\u2019s disease: vestibular signs that specify completion of therapy. Am J Otol. 1999;20(2):209\u201319.","journal-title":"Am J Otol"},{"issue":"3","key":"341_CR46","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/01.mao.0000169778.54162.7d","volume":"26","author":"N Goksu","year":"2005","unstructured":"Goksu N et al. Combined retrosigmoid retrolabyrinthine vestibular nerve section: results of our experience over 10\u00a0years. Otol Neurotol. 2005;26(3):481\u20133.","journal-title":"Otol Neurotol"},{"issue":"3","key":"341_CR47","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00129492-200305000-00009","volume":"24","author":"LR Lustig","year":"2003","unstructured":"Lustig LR et al. Cochlear implantation in patients with bilateral Meniere\u2019s syndrome. Otol Neurotol. 2003;24(3):397\u2013403.","journal-title":"Otol Neurotol"},{"key":"341_CR48","doi-asserted-by":"crossref","unstructured":"Hillier SL and McDonnell M. Vestibular rehabilitation for unilateral peripheral vestibular dysfunction. Cochrane Database Syst Rev. 2011(2):CD005397. A systematic review that provided strong evidence that vestibular physical therapy is helpful in Meni\u00e8re\u2019s disease.","DOI":"10.1111\/j.1749-4486.2011.02309.x"},{"issue":"3","key":"341_CR49","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.apmr.2007.11.010","volume":"89","author":"MC Schubert","year":"2008","unstructured":"Schubert MC et al. Mechanism of dynamic visual acuity recovery with vestibular rehabilitation. Arch Phys Med Rehabil. 2008;89(3):500\u20137. An important study that helped elucidate the physiologic changes that occur with vestibular physical therapy.","journal-title":"Arch Phys Med Rehabil"},{"issue":"2","key":"341_CR50","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/MAO.0b013e3181c2dbae","volume":"31","author":"MC Schubert","year":"2010","unstructured":"Schubert MC et al. Oculomotor strategies and their effect on reducing gaze position error. Otol Neurotol. 2010;31(2):228\u201331.","journal-title":"Otol Neurotol"},{"issue":"2\u20133","key":"341_CR51","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3233\/VES-2008-182-308","volume":"18","author":"M Scherer","year":"2008","unstructured":"Scherer M, Migliaccio AA, Schubert MC. Effect of vestibular rehabilitation on passive dynamic visual acuity. J Vestib Res. 2008;18(2\u20133):147\u201357.","journal-title":"J Vestib Res"},{"issue":"5","key":"341_CR52","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1097\/00129492-200409000-00017","volume":"25","author":"CD Hall","year":"2004","unstructured":"Hall CD, Schubert MC, Herdman SJ. Prediction of fall risk reduction as measured by dynamic gait index in individuals with unilateral vestibular hypofunction. Otol Neurotol. 2004;25(5):746\u201351.","journal-title":"Otol Neurotol"},{"key":"341_CR53","first-page":"CD005397","volume":"1","author":"MN McDonnell","year":"2015","unstructured":"McDonnell MN, Hillier SL. Vestibular rehabilitation for unilateral peripheral vestibular dysfunction. Cochrane Database Syst Rev. 2015;1:CD005397.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"341_CR54","doi-asserted-by":"crossref","first-page":"366","DOI":"10.5935\/1808-8694.20130064","volume":"79","author":"AP Garcia","year":"2013","unstructured":"Garcia AP et al. Vestibular rehabilitation with virtual reality in Meniere\u2019s disease. Braz J Otorhinolaryngol. 2013;79(3):366\u201374. This study is important because it highlighted the use of virtual reality to deliver vestibular rehabilitation therapy to Meni\u00e8re\u2019s patient, and showed it to be highly effective.","journal-title":"Braz J Otorhinolaryngol"},{"issue":"4","key":"341_CR55","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1001\/archotol.133.4.383","volume":"133","author":"SJ Herdman","year":"2007","unstructured":"Herdman SJ et al. Recovery of dynamic visual acuity in bilateral vestibular hypofunction. Arch Otolaryngol Head Neck Surg. 2007;133(4):383\u20139.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"8","key":"341_CR56","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1001\/archotol.129.8.819","volume":"129","author":"SJ Herdman","year":"2003","unstructured":"Herdman SJ et al. Recovery of dynamic visual acuity in unilateral vestibular hypofunction. Arch Otolaryngol Head Neck Surg. 2003;129(8):819\u201324.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"341_CR57","doi-asserted-by":"crossref","unstructured":"Syed MI et al. Positive pressure therapy for Meniere\u2019s syndrome\/ disease with a Meniett device: A systematic review of randomised controlled trials. Clin Otolaryngol. 2014. A systematic review that examined the evidence for the Meniett device.","DOI":"10.1111\/coa.12344"},{"key":"341_CR58","doi-asserted-by":"crossref","unstructured":"Ahsan SF, Standring R and Wang Y. Systematic review and meta-analysis of Meniett therapy for Meniere\u2019s disease. Laryngoscope. 2014. Another systematic review that looked at evidence for the Meniett device","DOI":"10.1002\/lary.24773"},{"issue":"7","key":"341_CR59","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1097\/MAO.0b013e318263d35d","volume":"33","author":"PR Lambert","year":"2012","unstructured":"Lambert PR et al. A randomized, double-blind, placebo-controlled clinical study to assess safety and clinical activity of OTO-104 given as a single intratympanic injection in patients with unilateral Meniere's disease. Otol Neurotol. 2012;33(7):1257\u201365. This study is important because it examined a novel delivery vehicle for intratympanic dexamethesone, which has been proven to be an effective, non-ablative treatment.","journal-title":"Otol Neurotol"},{"key":"341_CR60","unstructured":"ClinicalTrials.gov. OTO-104 for the Treatment of Meniere\u2019s Disease. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT01412177?term=meniere%27s&rank=4"},{"issue":"2","key":"341_CR61","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1001\/archotol.1978.00790020041009","volume":"104","author":"J Stahle","year":"1978","unstructured":"Stahle J, Stahle C, Arenberg IK. Incidence of Meniere\u2019s disease. Arch Otolaryngol. 1978;104(2):99\u2013102.","journal-title":"Arch Otolaryngol"},{"issue":"9 Pt 1","key":"341_CR62","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/lary.1978.88.9.1504","volume":"88","author":"WL Meyerhoff","year":"1978","unstructured":"Meyerhoff WL, Paparella MM, Shea D. Meniere\u2019s disease in children. Laryngoscope. 1978;88(9 Pt 1):1504\u201311.","journal-title":"Laryngoscope"},{"issue":"2","key":"341_CR63","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1017\/S0022215100096523","volume":"99","author":"R Filipo","year":"1985","unstructured":"Filipo R, Barbara M. Juvenile Meniere\u2019s disease. J Laryngol Otol. 1985;99(2):193\u20136.","journal-title":"J Laryngol Otol"},{"issue":"4","key":"341_CR64","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0196-0709(87)80001-7","volume":"8","author":"R Hausler","year":"1987","unstructured":"Hausler R et al. Meniere\u2019s disease in children. Am J Otolaryngol. 1987;8(4):187\u201393.","journal-title":"Am J Otolaryngol"},{"issue":"3","key":"341_CR65","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0165-5876(01)00576-6","volume":"61","author":"H Akagi","year":"2001","unstructured":"Akagi H et al. Meniere\u2019s disease in childhood. Int J Pediatr Otorhinolaryngol. 2001;61(3):259\u201364.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"341_CR66","unstructured":"Medicine, O.C.f.E.B. Levels of Evidence. 2009 [cited 2015 Jan 16]; Available from: http:\/\/www.cebm.net\/oxford-centre-evidence-based-medicine-levels-evidence-march-2009\/"},{"issue":"1","key":"341_CR67","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/01.mao.0000233815.71671.6c","volume":"28","author":"RC Diaz","year":"2007","unstructured":"Diaz RC et al. Quality-of-life assessment of Meniere\u2019s disease patients after surgical labyrinthectomy. Otol Neurotol. 2007;28(1):74\u201386.","journal-title":"Otol Neurotol"},{"issue":"2","key":"341_CR68","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1742-1241.2011.02842.x","volume":"66","author":"I Syed","year":"2012","unstructured":"Syed I, Aldren C. Meniere\u2019s disease: an evidence based approach to assessment and management. Int J Clin Pract. 2012;66(2):166\u201370.","journal-title":"Int J Clin Pract"},{"issue":"5","key":"341_CR69","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.otc.2010.05.003","volume":"43","author":"SD Rauch","year":"2010","unstructured":"Rauch SD. Clinical hints and precipitating factors in patients suffering from Meniere\u2019s disease. Otolaryngol Clin North Am. 2010;43(5):1011\u20137.","journal-title":"Otolaryngol Clin North Am"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-015-0341-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11940-015-0341-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-015-0341-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T17:40:08Z","timestamp":1651426808000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11940-015-0341-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,10]]},"references-count":69,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["341"],"URL":"https:\/\/doi.org\/10.1007\/s11940-015-0341-x","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,10]]},"article-number":"14"}}